Marta-Ines Castillejo
Overview
Explore the profile of Marta-Ines Castillejo including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
186
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Yee M, Josephson C, Hill C, Harrington R, Castillejo M, Ramjit R, et al.
J Pediatr Hematol Oncol
. 2013 Apr;
35(7):e301-5.
PMID: 23619115
The opioid medications codeine and hydrocodone, commonly prescribed in sickle cell disease (SCD), require metabolic conversion by cytochrome P450 2D6 (CYP2D6) to morphine and hydromorphone, respectively, to exert their analgesic...
2.
Josephson C, Granger S, Assmann S, Castillejo M, Strauss R, Slichter S, et al.
Blood
. 2012 Apr;
120(4):748-60.
PMID: 22538854
Age-group analyses were conducted of patients in the prophylactic platelet dose trial (PLADO), which evaluated the relation between platelet dose per transfusion and bleeding. Hospitalized patients with treatment-induced hypoproliferative thrombocytopenia...
3.
Josephson C, Castillejo M, Caliendo A, Waller E, Zimring J, Easley K, et al.
Transfus Med Rev
. 2011 Feb;
25(2):125-32.
PMID: 21345642
The transfusion-transmitted cytomegalovirus (TT-CMV) can cause serious morbidity and mortality in low-birth weight infants (LBWIs). Transfusion-transmitted cytomegalovirus can be minimized in LBWIs born to cytomegalovirus (CMV)-seronegative mothers with the use...
4.
Josephson C, Wesolowski A, Bao G, Sola-Visner M, Dudell G, Castillejo M, et al.
J Pediatr
. 2010 Jul;
157(6):972-978.e1-3.
PMID: 20650470
Objective: To test the hypothesis that red blood cell (RBC) transfusions increase the risk of necrotizing enterocolitis (NEC) in premature infants, we investigated whether the risk of "transfusion-associated" NEC is...
5.
Winkler A, Sheppard C, Culler E, Myers R, Duncan A, Castillejo M, et al.
Transfusion
. 2010 May;
50(10):2193-8.
PMID: 20456709
Background: Platelet (PLT) storage adversely affects PLT structure and function in vitro and is associated with decreased PLT recovery and function in vivo. In pediatric transfusion medicine, it is not...
6.
Josephson C, Castillejo M, Grima K, Hillyer C
Transfus Apher Sci
. 2009 Dec;
42(1):83-8.
PMID: 20034854
Clinically significant hemolysis is a rare but potentially severe complication of administering an ABO-mismatched platelet transfusion. Platelet products from Group O donors, particularly single donor platelets (SDP) are most commonly...
7.
McPherson M, Anderson A, Castillejo M, Hillyer C, Bray R, Gebel H, et al.
Pediatr Blood Cancer
. 2009 Nov;
54(4):552-8.
PMID: 19890898
Background: Alloimmunization to minor red blood cell (RBC) antigens occurs commonly in sickle cell disease (SCD). Patients with alloimmunization demonstrate increased risk for new alloantibody formation with subsequent transfusion. Alloimmunization...
8.
McPherson M, Anderson A, Haight A, Jessup P, Castillejo M, Hillyer C, et al.
Transfusion
. 2009 May;
49(9):1977-86.
PMID: 19453984
Background: Sickle cell disease (SCD) patients have unique transfusion considerations during bone marrow transplantation (BMT), including prophylaxis against stroke and alloimmunization. Characterization of transfusion requirements is important for blood bank...
9.
Josephson C, Su L, Christensen R, Hillyer C, Castillejo M, Emory M, et al.
Pediatrics
. 2009 Jan;
123(1):278-85.
PMID: 19117893
Objective: In the absence of scientific evidence, current neonatal platelet transfusion practices are based on physicians' preferences, expert advice, or consensus-driven recommendations. We hypothesized that there would be significant diversity...
10.
Culler E, Hillyer C, Haight A, Castillejo M, Josephson C
Pediatr Blood Cancer
. 2007 Mar;
50(3):660-2.
PMID: 17330834
Anti-CD36 antibodies are known to cause a platelet refractory state. We describe a previously unreported case of a 16-year-old female sickle cell disease patient with anti-CD36 antibodies, detected on routine...